The Relationship Between Abnormal Modified Schober Index and Demographic Characteristics and Clinical Variables
Launched by MUSTAFA KEMAL UNIVERSITY · Oct 18, 2022
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
Ankylosing spondylitis (AS), a common type of spondyloarthropathy, is a chronic inflammatory disease that affects spinal joints, and adjacent soft tissues such as sacroiliac joints, tendons, and entheses (1). Inflammation of the spinal structures and progressive changes in the surrounding tissue is largely responsible for decreased physical function and mobility in participants with AS (2).
It is unknown how these parameters of AS participants with AMSI (smaller than 5 cm) are affected compared to AS participants with normal modified Schober index (NMSI, bigger than 5 cm). In addition, it ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants who meet the modified New York criteria for AS
- • Participants over 18 years
- Exclusion Criteria:
- • Participants with other concomitant rheumatic diseases (such as fibromyalgia, rheumatoid arthritis, etc.),
- • Participants with cognitive or psychiatric disorders,
- • Participants with neuromuscular or orthopedic diseases
About Mustafa Kemal University
Mustafa Kemal University is a prominent academic institution located in Hatay, Turkey, dedicated to advancing education, research, and healthcare. The university actively engages in clinical research through its affiliated medical and health sciences departments, contributing to the development of innovative treatments and healthcare solutions. With a commitment to scientific excellence and ethical standards, Mustafa Kemal University collaborates with various stakeholders to conduct rigorous clinical trials that aim to enhance patient care and improve health outcomes. Their research initiatives are designed to foster knowledge translation and promote evidence-based practices within the medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hatay, Alahan, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials